 |
PDBsum entry 2rjp
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Crystal structure of adamts4 with inhibitor bound
|
|
Structure:
|
 |
Adamts-4. Chain: a, b, c, d. Fragment: residues 213-520. Synonym: a disintegrin and metalloproteinase with thrombospondin motifs 4, adam-ts 4, adam-ts4, aggrecanase-1, admp-1. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: adamts4, kiaa0688. Expressed in: cricetulus griseus. Expression_system_taxid: 10029. Expression_system_cell_line: ovary (cho) cells
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.209
|
R-free:
|
0.267
|
|
|
Authors:
|
 |
L.Mosyak,M.Stahl,W.Somers
|
Key ref:
|
 |
L.Mosyak
et al.
(2008).
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5.
Protein Sci,
17,
16-21.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
15-Oct-07
|
Release date:
|
11-Dec-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
O75173
(ATS4_HUMAN) -
A disintegrin and metalloproteinase with thrombospondin motifs 4 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
837 a.a.
291 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.24.82
- Adamts-4 endopeptidase.
|
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Protein Sci
17:16-21
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5.
|
|
L.Mosyak,
K.Georgiadis,
T.Shane,
K.Svenson,
T.Hebert,
T.McDonagh,
S.Mackie,
S.Olland,
L.Lin,
X.Zhong,
R.Kriz,
E.L.Reifenberg,
L.A.Collins-Racie,
C.Corcoran,
B.Freeman,
R.Zollner,
T.Marvell,
M.Vera,
P.E.Sum,
E.R.Lavallie,
M.Stahl,
W.Somers.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Aggrecanases are now believed to be the principal proteinases responsible for
aggrecan degradation in osteoarthritis. Given their potential as a drug target,
we solved crystal structures of the two most active human aggrecanase isoforms,
ADAMTS4 and ADAMTS5, each in complex with bound inhibitor and one wherein the
enzyme is in apo form. These structures show that the unliganded and
inhibitor-bound enzymes exhibit two essentially different catalytic-site
configurations: an autoinhibited, nonbinding, closed form and an open, binding
form. On this basis, we propose that mature aggrecanases exist as an ensemble of
at least two isomers, only one of which is proteolytically active.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 2.
Figure 2. Molecular surfaces of the active sites with inhibitor bound and detailed view of the interactions involved. (A) Stereo surface
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from the Protein Society:
Protein Sci
(2008,
17,
16-21)
copyright 2008.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.S.Shieh,
A.G.Tomasselli,
K.J.Mathis,
M.E.Schnute,
S.S.Woodard,
N.Caspers,
J.M.Williams,
J.R.Kiefer,
G.Munie,
A.Wittwer,
A.M.Malfait,
and
M.D.Tortorella
(2011).
Structure analysis reveals the flexibility of the ADAMTS-5 active site.
|
| |
Protein Sci,
20,
735-744.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Zhou,
X.Dong,
C.Baldauf,
H.Chen,
Y.Zhou,
T.A.Springer,
X.Luo,
C.Zhong,
F.Gräter,
and
J.Ding
(2011).
A novel calcium-binding site of von Willebrand factor A2 domain regulates its cleavage by ADAMTS13.
|
| |
Blood,
117,
4623-4631.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Cappelli,
C.Nannicini,
S.Valenti,
G.Giuliani,
M.Anzini,
L.Mennuni,
A.Giordani,
G.Caselli,
L.P.Stasi,
F.Makovec,
G.Giorgi,
and
S.Vomero
(2010).
Design, synthesis, and preliminary biological evaluation of pyrrolo[3,4-c]quinolin-1-one and oxoisoindoline derivatives as aggrecanase inhibitors.
|
| |
ChemMedChem,
5,
739-748.
|
 |
|
|
|
|
 |
N.H.Lim,
M.Kashiwagi,
R.Visse,
J.Jones,
J.J.Enghild,
K.Brew,
and
H.Nagase
(2010).
Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.
|
| |
Biochem J,
431,
113-122.
|
 |
|
|
|
|
 |
R.de Groot,
D.A.Lane,
and
J.T.Crawley
(2010).
The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity.
|
| |
Blood,
116,
3064-3072.
|
 |
|
|
|
|
 |
H.B.Feys,
I.Pareyn,
R.Vancraenenbroeck,
M.De Maeyer,
H.Deckmyn,
C.Van Geet,
and
K.Vanhoorelbeke
(2009).
Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura.
|
| |
Blood,
114,
4749-4752.
|
 |
|
|
|
|
 |
H.E.Miwa,
T.A.Gerken,
T.D.Huynh,
L.R.Duesler,
M.Cotter,
and
T.M.Hering
(2009).
Conserved sequence in the aggrecan interglobular domain modulates cleavage by ADAMTS-4 and ADAMTS-5.
|
| |
Biochim Biophys Acta,
1790,
161-172.
|
 |
|
|
|
|
 |
H.Liu,
A.H.Shim,
and
X.He
(2009).
Structural characterization of the ectodomain of a disintegrin and metalloproteinase-22 (ADAM22), a neural adhesion receptor instead of metalloproteinase: insights on ADAM function.
|
| |
J Biol Chem,
284,
29077-29086.
|
 |
|
|
|
|
 |
L.Troeberg,
K.Fushimi,
S.D.Scilabra,
H.Nakamura,
V.Dive,
I.B.Thøgersen,
J.J.Enghild,
and
H.Nagase
(2009).
The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.
|
| |
Matrix Biol,
28,
463-469.
|
 |
|
|
|
|
 |
M.Akiyama,
S.Takeda,
K.Kokame,
J.Takagi,
and
T.Miyata
(2009).
Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor.
|
| |
Proc Natl Acad Sci U S A,
106,
19274-19279.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Akiyama,
S.Takeda,
K.Kokame,
J.Takagi,
and
T.Miyata
(2009).
Production, crystallization and preliminary crystallographic analysis of an exosite-containing fragment of human von Willebrand factor-cleaving proteinase ADAMTS13.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
65,
739-742.
|
 |
|
|
|
|
 |
M.D.Gardner,
C.K.Chion,
R.de Groot,
A.Shah,
J.T.Crawley,
and
D.A.Lane
(2009).
A functional calcium-binding site in the metalloprotease domain of ADAMTS13.
|
| |
Blood,
113,
1149-1157.
|
 |
|
|
|
|
 |
S.Takeda
(2009).
Three-dimensional domain architecture of the ADAM family proteinases.
|
| |
Semin Cell Dev Biol,
20,
146-152.
|
 |
|
|
|
|
 |
W.Gao,
P.J.Anderson,
and
J.E.Sadler
(2008).
Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity.
|
| |
Blood,
112,
1713-1719.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |